ERBB2 and gastric cancer: ERBB2 overexpression (scores of 2 + and 3+) according to the ASCO/CAP 2017 guidelines in GC was seen in 3, 22, and 36 UTUCs, with WHO grades of 1, 2, or 3, respectively.